Michael Leo to Risk Assessment
This is a "connection" page, showing publications Michael Leo has written about Risk Assessment.
Connection Strength
0.286
-
External validation of the EORTC and NCCN bladder cancer recurrence and progression risk calculators in a U.S. community-based health system. Urol Oncol. 2020 02; 38(2):39.e21-39.e27.
Score: 0.126
-
Patient randomized trial of a targeted navigation program to improve rates of follow-up colonoscopy in community health centers. Contemp Clin Trials. 2020 02; 89:105920.
Score: 0.032
-
Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer. Perm J. 2019; 23.
Score: 0.031
-
Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision Making. Health Aff (Millwood). 2018 05; 37(5):809-816.
Score: 0.028
-
Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers. J Am Heart Assoc. 2017 Jul 03; 6(7).
Score: 0.027
-
Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting. J Urol. 2016 06; 195(6):1748-53.
Score: 0.024
-
Sleep-wake patterns of school-age children and adolescents before diagnosis and during induction chemotherapy for acute lymphocytic leukemia. J Pediatr Nurs. 2011 Dec; 26(6):e37-44.
Score: 0.018